Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Dev Neurosci ; 35(2-3): 172-81, 2013.
Article in English | MEDLINE | ID: mdl-23445561

ABSTRACT

Epidemiological and experimental data implicate maternal infection and inflammation in the etiology of brain white matter injury, which may lead to cerebral palsy in preterm newborns. Our aim was to investigate motor development of the offspring after maternal administration of lipopolysaccharide (LPS). Wistar rats were intraperitoneally injected with Escherichia coli LPS or saline on gestational days 19 and 20. From birth to 3 weeks, pups were tested for neurobehavioral development, neurological signs and reflexes. From 3 to 6 weeks, motor coordination was investigated. At 4 months, animals were tested for locomotion. Brain myelination was assessed by myelin basic protein immunohistochemistry. Days of appearance of several neurological reflexes were significantly delayed, and neonate LPS pups displayed retarded performance in righting, gait and negative geotaxis. At the juvenile stage, LPS animals showed important impairment in coordination. However, although the LPS group performed worse in most tests, they reached vehicle levels by 5 weeks. At 4 months, LPS animals did not show variations in locomotion performances compared to vehicle. No myelination differences have been observed in the brains at adulthood. Maternal LPS administration results in delayed motor development even though these alterations fade to reach control level by 5 weeks. Motor impairments observed at the early stage in this study could be linked to previously reported hypomyelination of the white matter induced by maternal LPS challenge in the neonates. Finally, the normal myelination shown here at adulthood may explain the functional recovery of the animals and suggest either a potential remyelination of the brain or a delayed myelination in LPS pups.


Subject(s)
Brain/pathology , Inflammation/pathology , Lipopolysaccharides/toxicity , Maternal Exposure/adverse effects , Motor Skills/drug effects , Animals , Animals, Newborn , Behavior, Animal/drug effects , Brain/physiopathology , Cerebral Palsy/etiology , Disease Models, Animal , Female , Immunohistochemistry , Inflammation/chemically induced , Inflammation/physiopathology , Male , Motor Skills/physiology , Nerve Fibers, Myelinated/drug effects , Nerve Fibers, Myelinated/pathology , Rats , Rats, Wistar
2.
ACS Nano ; 4(9): 5339-49, 2010 Sep 28.
Article in English | MEDLINE | ID: mdl-20795638

ABSTRACT

We report the fine-tuning of the relaxometry of gamma-Fe2O3@SiO2 core-shell nanoparticles by adjusting the thickness of the coated silica layer. It is clear that the coating thickness of Fe2O3@SiO2 nanoparticles has a significant impact on the r(1) (at low B0 fields), r(2), and r(2)* relaxivities of their aqueous suspensions. These studies clearly indicate that the silica layer is heterogeneous and has regions that are porous to water and others-that are not. It is also shown, that the viability and the mitochondrial dehydrogenase expression of the microglial cells do not appear to be sensitive to the vesicular load with these core-shell nanoparticles. The adequate silica-shell thickness can therefore be tuned to allow for both a sufficiently high response as contrast agent, and-adequate grafting of targeted biomolecules.


Subject(s)
Ferric Compounds/chemistry , Nanoparticles/chemistry , Nanotechnology/methods , Silicon Dioxide/chemistry , Cell Line , Cell Survival/drug effects , Magnetic Resonance Spectroscopy , Microglia/cytology , Microglia/drug effects , Microscopy, Electron, Transmission , Nanoparticles/toxicity , Particle Size , Porosity , Time Factors , Water/chemistry
3.
J Neuropathol Exp Neurol ; 67(10): 994-1000, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18800008

ABSTRACT

Intracerebral injection of ibotenate in newborn rodents produces brain damage that mimics that of infants with cerebral palsy. Because maternal infection may contribute to brain injury in preterm infants, we investigated brain damage after maternal inflammation and postnatal ibotenate treatment in a rat model of cerebral palsy. Pregnant rats were injected intraperitoneally with lipopolysaccharide at Days 19 and 20 of gestation. Neonates were given intracerebral injections of ibotenate at postnatal Day 4 and were then killed at Day 9. Lesion sizes were measured by cresyl violet staining, and microglial activation, astrogliosis, and myelination were evaluated by immunohistochemistry. The lipopolysaccharide groups had larger cortical and white matter lesions than the control group; they also had significantly greater microglial activation and astrogliosis and less white matter myelination in the lesioned hemispheres compared with the controls. Thus, maternal endotoxin exposure may affect prenatal development of the offspring and modulate the subsequent development of excitotoxic brain lesions. These results demonstrate the critical influence of prenatal immune events on neonatal central nervous system vulnerability and provide a model for studying the pathophysiology of cerebral damage in preterm infants and, specifically, the interplay between brain inflammation and excitotoxicity.


Subject(s)
Animals, Newborn/physiology , Brain/drug effects , Brain/pathology , Endotoxins/toxicity , Excitatory Amino Acid Agonists/toxicity , Ibotenic Acid/toxicity , Lipopolysaccharides/toxicity , Animals , CD11b Antigen/metabolism , Female , Glial Fibrillary Acidic Protein/metabolism , Gliosis/pathology , Immunohistochemistry , Microglia/pathology , Myelin Basic Protein/metabolism , Myelin Sheath/pathology , Nerve Fibers/pathology , Pregnancy , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...